Recent SEC Filings
| Entity | Filing | Filed On |
|---|---|---|
| 4D Molecular Therapeutics Inc | 10-Q | 13 Nov 2024 |
| Natural Alternatives International Inc | FORM 10-Q | 13 Nov 2024 |
| RenovoRx Inc | 10-Q | 13 Nov 2024 |
| Cantor Equity Partners Inc | QUARTERLY REPORT | 13 Nov 2024 |
| Dermata Therapeutics Inc | FORM 10-Q | 13 Nov 2024 |
| Structure Therapeutics Inc | 10-Q | 13 Nov 2024 |
| Armata Pharmaceuticals Inc | 10-Q | 13 Nov 2024 |
| /entities/omcc | 10-Q | 13 Nov 2024 |
| T Series Middle Market Loan Fund LLC | 10-Q | 13 Nov 2024 |
| Enliven Therapeutics Inc | 10-Q | 13 Nov 2024 |
| electroCore, Inc. | 10-Q | 13 Nov 2024 |
| Energous Corp | 10-Q | 13 Nov 2024 |
| Sonim Technologies Inc | 10-Q | 13 Nov 2024 |
| NSTS Bancorp Inc | FORM 10-Q | 13 Nov 2024 |
| Vaxart Inc | FORM 10-Q | 13 Nov 2024 |
| Evolution Petroleum Corp | 10-Q | 13 Nov 2024 |
| Zevra Therapeutics Inc | FORM 10-Q | 13 Nov 2024 |
| DiaMedica Therapeutics Inc | FORM 10-Q | 13 Nov 2024 |
| Ashford Inc. | 10-Q | 13 Nov 2024 |
| Cardio Diagnostics Holdings Inc | FORM 10-Q | 13 Nov 2024 |
